The global commercial seed market has grown substantially in value, rising from $36 billion in 2007 to more than $50 billion in 2020 according to the FAO. ² Within that growing sector, questions of who controls seed supply, what happens to crop genetic diversity, and how intellectual property and regulation shape farmer choices form three distinct but connected lines of inquiry.

The evidence base spans authoritative UN and national institutions, peer-reviewed journals, market research, and advocacy organizations. That mix matters: some figures carry the weight of official statistics, while others rest on a single advocacy source or represent explicit forecasts. This report treats each grade explicitly, distinguishing what is confirmed from what is reported, contested, or speculative.

The core concentration figures are attributed to official U.S. sources. DTN/Progressive Farmer, citing a June 2023 USDA Economic Research Service report, reports that AgReliant, Bayer, Corteva and Syngenta together accounted for 83.4% of U.S. corn seed sales and 78.1% of soybean seed sales over 2018-2020. ¹ A 2023 USDA Agricultural Marketing Service report is cited for even tighter control of intellectual property: 95% of corn IP and 84% of soybean IP held by BASF, Bayer, Corteva and Syngenta. ¹ A March 2023 USDA-AMS report is cited for the scale of consolidation over time — more than 200 seed companies acquired or closed since the early 1990s. ¹

At the global level, ETC Group reports that BASF, Bayer, Corteva and Syngenta controlled 56% of the global commercial seed market in 2023, with Bayer alone accounting for 23%. ¹ The analyst confirmed ETC Group's figures are internally consistent — US$27,958 million against a US$50,000 million world market computes to 55.9%, which ETC rounds to 56% — but this checks arithmetic only, not the accuracy of the underlying sales or market-size inputs, which rest on ETC Group alone. ¹ The analyst also notes that the higher U.S. crop-specific shares (83.4% corn, 78.1% soybean) and the lower 56% global share are not in conflict — they use different denominators, U.S. retail crop sales versus the global market across all seed types, and the U.S. market is more consolidated. ²

Consolidation continues at the brand level. DTN/Progressive Farmer reports that in 2025, farmers in more than 20 U.S. states will have fewer seed brands available after Bayer consolidated 10 regional brands under the Channel brand. ¹ Farm Aid reports that Corteva and Bayer alone accounted for more than half of U.S. retail corn, soybean and cotton seed sales between 2018 and 2020. ¹

Several of these figures depend on a single origin. The 83.4% corn share, the 95%/84% IP concentration, and the 200-plus company count all reach the record only through DTN/Progressive Farmer citing USDA reports, with no independent corroboration in this dossier. ¹ The global 56% figure, by contrast, is corroborated at the ~56-60% level by a second, differently-positioned source, strengthening confidence in the broad concentration picture even where specific numbers rest on one origin. ¹

Open: Do the original USDA-ERS (June 2023) and USDA-AMS (March 2023) reports confirm the 83.4%, 78.1%, 95% and 84% figures as attributed?; Which four companies does each ~56-60% global estimate reference, given the BASF-versus-AgReliant difference between the U.S. and global groupings?

The headline economic-harm figure comes from a single advocacy source. Farm Aid, citing USDA data, reports that the average price of seed rose 270% between 1990 and 2020 while the price of commodity crops rose only 56%. ¹ If accurate, that is roughly a fivefold disparity in cumulative inflation over three decades.

The analyst flags material limitations. This is the only estimate of its kind in the evidence set, drawn from an advocacy origin, with no independent corroboration. ¹ The 30-year window captures multiple structural shifts — biotech introduction, consolidation waves, patent expansions — and the figures are presented without inflation adjustment, without the yield gains or R&D costs that might contextualize seed prices, and with 'commodity crops' as an aggregate that may mask crop-specific movements. ¹

A related contested figure concerns market structure. Farm Aid states that three companies control almost 60% of the seed and agrochemical markets. ¹ This conflicts with other sources — including ETC Group's 56% figure — which attribute comparable concentration to four companies, not three. ² The analyst notes the discrepancy may reflect Farm Aid combining seed and agrochemical markets, a different geographic definition, or a simple error in company count, and cannot be resolved from the record. ¹

The severity of consolidation for independent firms is expressed as a forecast rather than a documented outcome. Todd Martin, CEO of the Independent Professional Seed Association, predicts that unless action is taken on competition and IP patents, fewer than 40 independent seed companies will remain within five years. ¹ This is a speculative prediction by a figure whose members face direct competitive pressure, and it should be read as an advocacy warning, not an established trajectory. ¹

Open: Can the 270% seed / 56% crop price figures be confirmed against USDA price archives in real, inflation-adjusted terms?; Are there farmer-level cost or variety-choice studies comparing concentrated and fragmented seed markets?

The authoritative diversity-loss figures come from the FAO. The agency confirms that more than 40% of all plant taxa surveyed are no longer present in at least one area where they were previously cultivated or occurred naturally, and that about one-third of tree species are threatened. ¹ The Council on Library and Information Resources, citing FAO, reports that 75% of crop diversity was lost between 1900 and 2000. ¹ CLIR also documents a dramatic historical narrowing of U.S. varieties: maize varieties fell from 307 in 1903 to 12 in 1983, and tomato varieties from 408 to 79. ¹

A direct conflict exists over the 75% figure. Scientifica reports that almost 75% of the world's crop genetic diversity was lost during the past 20 years due to extensive use of commercial hybrid and GM crops. ¹ FAO, via CLIR, attributes the same 75% figure to the full century 1900-2000 and to general agricultural modernization. ¹ The Scientifica figure applies the canonical 75% FAO statistic to an incompatible two-decade window with a single causal mechanism, conflicting with the well-established FAO attribution of that number to 1900-2000 and to general agricultural modernization. ² The two claims cannot both be correct; the CLIR/FAO attribution is the well-established one.

Preservation efforts are documented and expanding. FAO reports an 8% increase in germplasm collection preservation since 2009. ¹ The Svalbard Global Seed Vault confirms it received over 30,000 new seed samples on 22 October 2024 from 23 depositors across 21 countries, including first-time contributions from genebanks in Bangladesh, Bolivia, Chad, Nigeria, Papua New Guinea and Suriname. ¹ CLIR reports over 2,000 open seed libraries documented across 15 countries and 48 U.S. states as of March 2024. ¹ Crop Trust executive director Stefan Schmitz states that climate change and conflict threaten food security for over 700 million people in more than 75 countries. ¹

Several of these details are single-source. The specific U.S. variety counts, the Nepal yield studies discussed below, and the 2,000-library figure each rest on one origin. ¹ The FAO and Svalbard figures, by contrast, carry primary-institutional authority within their remit. ²

Open: What does the original FAO State of the World's Plant Genetic Resources report state about the timeframe and drivers of the 75% loss?; Do the 'lost' varieties survive in genebanks or marginal cultivation, or are they extinct — a distinction the sources do not consistently draw?

The United States operates two IP tracks with sharply different rules for farmers. University of Maryland Extension reports that U.S. Patent Law prohibits saving harvested seed for planting with no exceptions, including on a farmer's own land. ¹ By contrast, the Plant Variety Protection Act allows farmers who purchased PVPA-protected seed to save harvested seed for planting on their own holdings, while prohibiting sale or transfer. ¹ Which regime applies varies by crop: less than 25% of wheat varieties sold in Maryland are PVPA-protected, while most soybean varieties are protected under patent law. ¹

Internationally, the UPOV Convention's 1991 Act grants plant breeder's rights for a period of no less than 20 years, and UPOV had 75 member states as of February 2019. ¹ GMO oversight follows divergent models: the U.S. has regulated genetically modified products since 1986 under the Coordinated Framework administered by USDA, EPA and FDA, while the EU governs GMOs under Directive 2001/18/EC and Regulations 1829/2003 and 1830/2003 under the precautionary principle. ¹ Bio Eco Actual reports the EU is now revising its seed and plant-reproductive-material rules, replacing more than ten pieces of legislation, some dating to the 1960s. ¹

A counterweight exists in international law. Bio Eco Actual reports that farmers' right to save, reuse and exchange seeds is recognised under the UN Declaration on the Rights of Peasants and the International Treaty on Plant Genetic Resources for Food and Agriculture. ¹ The dossier does not contain evidence on how these instruments are enforced against domestic patent law, so their practical weight against national patent regimes cannot be assessed from the record. ¹

The evidence health here is adequate but structurally thin: the fundamental legal frameworks are confirmed, but no primary regulatory sources (patent offices, the UPOV office, EU official documentation) appear in the dossier, and localized details such as the Maryland crop mix and the EU revision are each single-source. ³

Open: Does UPOV membership and the minimum 20-year term hold as reported against the treaty organization's own records?; How is farmer seed-saving actually enforced where UNDROP/IT-PGRFA rights collide with patent law?

The central dispute is whether documented concentration constitutes harm. Four hypotheses organize the evidence.

H1 — that consolidation has reduced competition, raised costs, and narrowed choice — is supported on its structural elements. The concentration is documented at both U.S. and global levels, the pace of company disappearance is reported, and brand consolidation is ongoing. ² If H1's harm component were fully established, we would expect corroborated, context-adjusted price data and farmer-outcome studies; instead the key price figure is single-source advocacy data lacking yield and R&D context, and the most dramatic consolidation outcome is a speculative forecast. ² The structure is proven; the causal harm is asserted more than demonstrated.

H2 — that commercial hybrid and GM adoption drove crop-diversity loss — is supported on the loss itself but weakened on causation and timing. FAO confirms extensive taxa loss and the 75% figure for 1900-2000. ² The one claim that pins that loss on hybrids and GM crops over the past 20 years contradicts the established FAO timeline and appears to misattribute the canonical statistic. ¹ If hybrid/GM adoption were the compressed recent cause, we would expect the authoritative source to say so; it does not.

H3 — that hybrid and GM yield gains justify consolidation and higher costs — remains plausible but under-evidenced. Scientifica reports maize yield gains up to 30% and rice gains of 20-25% in Nepal, and Market.us reports GM seeds at 55.6% of the 2023 market. ² All three are single-source, and the Nepal figures are localized with no broader geographic validation. ¹ The gains are real where measured but cannot alone settle the net-benefit question against the price and diversity concerns.

H4 — that IP and regulatory frameworks enable concentration — is plausible. Patent prohibitions on seed-saving, the PVPA regime, and the UPOV minimum term supply the mechanism, while GMO frameworks structure market entry. ⁴ The countervailing farmers'-rights instruments exist but lack enforcement. ¹ The dossier documents the legal architecture but contains no comparative market-structure analysis across IP regimes that would confirm the causal link to concentration.

Open: Would meta-analyses of hybrid/GM yield trials across agroecological zones confirm the net-benefit case in H3?; Does market structure differ measurably across jurisdictions with stronger versus weaker IP regimes, as H4 predicts?

The evidence forces a clear conclusion on structure. Corporate concentration in commercial seed markets is documented at both national and global levels, corroborated across independently positioned sources at the ~56-60% global level and attributed to official USDA data for the higher U.S. crop-specific figures. ² The verified arithmetic behind the 56% figure adds confidence. ¹ That crop genetic diversity has declined substantially over the twentieth century is confirmed by FAO authority. ²

The evidence does not force the stronger claims. The magnitude of farmer economic harm rests on a single advocacy figure stripped of yield, R&D, and inflation context; the prediction of independent-sector collapse is speculative. ² The most alarmist biodiversity framing — 75% loss in 20 years from hybrids and GM crops — contradicts the authoritative FAO 1900-2000 timeline. ² Documented yield gains are genuine but local and single-source. ¹

The most defensible reading (labeled here as interpretive) is that the dossier establishes a highly concentrated, IP-shaped seed system atop a genuinely narrowed genetic base, but does not establish a proven causal chain from concentration to farmer harm or from commercial seeds to recent diversity loss. Preservation activity — expanding germplasm collections, Svalbard deposits, and thousands of seed libraries — runs alongside the concentration story rather than resolving it. ³ On the central question, the honest verdict is that structure is settled while consequence remains contested.